Abstract:Aging HSCs display a progressive and growth-factor sensitive elongation of G 1 . Increased growth-factor concentrations are required to stimulate mitogenesis in aging HSCs associated with reduced AKT activation. Human hematopoietic stem cells (HSCs), like their counterparts in mice, comprise a functionally and molecularly heterogeneous population of cells throughout life that, collectively, maintain required outputs of mature blood cellsunder homeostatic conditions. An early developmental change in the HSC population in both species includes a postnatal switch from most of these cells existing in a rapidly cycling state and maintenance of a high self-renewal potential to a majority in a quiescent state with an overall reduced self-renewal potential. However, despite the well-established growth factor dependence of HSC proliferation, if and how this mechanism of HSC regulation might be affected by aging has remained poorly understood. To address this gap, we isolated highly HSC-enriched CD34+CD38-CD45RA-CD90+CD49f+ (" CD49f+ ") cells from cord blood and adult bone marrow and mobilized peripheral blood samples obtained from normal humans spanning 7 decades of age and then measured their functional and molecular responses to growth-factor stimulation in vitro and regenerative activity in vivo in transplanted mice. Initial experiments revealed advancing donor age was accompanied by a significant and progressively delayed proliferative response but not the altered mature cell outputs seen in normal older individuals. Importantly, subsequent dose-response analyses revealed an age-associated reduction in the growth-factor stimulated proliferation of CD49f+ cells mediated by reduced intrinsic activation of AKT and altered cell-cycle entry and progression. These findings identify a new intrinsic, pervasive, and progressive aging-related alteration in the biological and signaling mechanisms required to drive the proliferation of very primitive normal human hematopoietic cells.

Age-related changes in the hematopoietic stem cell pool revealed via quantifying the balance of symmetric and asymmetric divisions

Cell division history determines hematopoietic stem cell potency

Large-Scale Clonal Analysis Resolves Aging of the Mouse Hematopoietic Stem Cell Compartment

Time-series analysis of hematopoietic stem cells

Aging is associated with functional and molecular changes in distinct hematopoietic stem cell subsets

Single-cell RNA-seq reveals a concomitant delay in differentiation and cell cycle of aged hematopoietic stem cells

Single Cell Transcriptomics to Understand HSC Heterogeneity and Its Evolution upon Aging

Aging alters the cell cycle control and mitogenic signaling responses of human hematopoietic stem cells

Increasing Neural Stem Cell Division Asymmetry and Quiescence Are Predicted to Contribute to the Age-Related Decline in Neurogenesis

Single-cell RNA-seq reveals changes in cell cycle and differentiation programs upon aging of hematopoietic stem cells

Combined Single-Cell Functional and Gene Expression Analysis Resolves Heterogeneity within Stem Cell Populations

The dynamics of hematopoiesis over the human lifespan

Hematopoietic stem cell heterogeneity and age-associated platelet bias are evolutionarily conserved

Reconstructing the in vivo dynamics of hematopoietic stem cells from telomere length distributions

Integrated Single-Cell Bioinformatics Analysis Reveals Intrinsic and Extrinsic Biological Characteristics of Hematopoietic Stem Cell Aging

An epigenetic component of hematopoietic stem cell aging amenable to reprogramming into a young state

Subtle Changes in Clonal Dynamics Underlie the Age-Related Decline in Neurogenesis

Natural and age-related variation in circulating human hematopoietic stem cells

Stable platelet production via the bypass pathway explains the long-term reconstitution capacity of hematopoietic stem cells

A Single-Cell Hematopoietic Landscape Resolves 8 Lineage Trajectories and Defects in Kit Mutant Mice.

Hematopoietic stem cell heterogeneity and age-related platelet bias: implications for bone marrow transplantation and blood disorders